News Focus
News Focus
icon url

no2koolaid

11/18/21 12:38 PM

#362340 RE: sharkey1 #362334

Hey, sharkey1...you know how Nasrat gets attacked for not making PRs on things like intended fillings, etc? Well, here is something to consider. J&J announced this TODAY...

Johnson & Johnson (JNJ) intends to file applications for 14 new drugs by 2025, with average peak sales of $4B for each of them, a company executive tells Reuters.



https://seekingalpha.com/news/3772449-johnson-johnson-janssen-expects-to-file-for-14-new-drugs-by-2025-reuters

And the reaction on the stock? It is DOWN 1/2 a percent. Perhaps investors should contemplate that before attacking Elite and Nasrat for the manipulated share price that they cannot control.